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Genetic control of the immune response to specific  antigens or specific  anti- 
genic determinants has now been demonstrated for a wide variety of antigens 
in several different animal species  (1). The ability of inbred strains of mice to 
produce antibody against branched, multichain, synthetic polypeptide antigens 
is a quantitative, autosomal dominant trait which has been shown to be linked 
to the major histocompatibility (I:t-2)  1 locus in the IXth mouse linkage group 
(2).  During the past 3 yr, specific  immune response genes in the mouse, the 
guinea  pig,  and  the  rat,  controlling  graft  rejection,  delayed sensitivity,  or 
antibody production to more than 20 different antigens, have all been shown to 
be linked to the genes controlling the species' major histocompatibility antigens 
(3).  The nature, significance, and extent of this relationship between specific 
immune response genes and histocompatibility antigens is not yet known. One 
important approach to this problem is  to determine the genetic relationship 
between murine-specific immune response genes and histocompatibility antigens 
by attempting to map the precise location of the immune response genes in the 
IXth mouse linkage group, with particular reference to the chromosome region 
controlling the histocompatibility (H-2) antigenic specificities. 
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bility-2 ; It-l, immune response-1 ; PBS, phosphate-buffered isotonic saline. 
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Sufficient knowledge of the IXth mouse linkage group (4), and of the genetic fine structure 
of the H-2 region  (5), is available to make such an attempt feasible. Fig.  1 is a  schematic 
diagram of the IXth mouse linkage group, with particular emphasis on the fine structure of 
the H-2 complex  (5). The  T-t complex maps closest to the centromere and consists of one 
dominant (T) and several recessive factors (t alleles) with a variety of effects on the develop- 
ment of thenotochord, neural tube, and spinal column (6). The dominant factor T  (brachyury) 
is apparently a point mutation which in the T/+  heterozygote leads to shortening of the tail. 
The homozygous T/T state is lethal. The tf (tufted) locus controls hair growth pattern (7). 
The tf/tf homozygote has an abnormal hair growth pattern with serial waves of hair loss pro- 
ceeding from head to tail, beginning at about the 7-8th wk of age. The H-2 complex is a large 
chromosomal region consisting of at least two loci, H-2K and H-2D, governing the antigenic 
specificities of the major histocompatibility antigens expressed on the cell surface. Crossing 
over has been demonstrated between H-2K and H-2D at a rate of about 0.5%. These two loci 
of the H-2 complex are separated by the Ss-Slp complex which controls a serum alpha globu- 
lin detectable by a  rabbit anti-mouse antiserum  (serologically detected  serum protein), as 
well as an aUotypic variation in the Ss protein which is expressed only in males and is there- 
fore designated as a sex-limited protein (Sip) (8). The Ss-Slp loci are closely linked, genetically 
indistinguishable loci, and are useful  markers for localization of crossovers within the H-2 
complex. There are two alleles of Ss, namely Ss  ~ and Ss  ~, for low and high levels of the Ss 
protein, as well as Slp ~ and Slp° which determine the presence or absence of the  allotypic 
variant of the Ss protein. Since the known H-2 alleles carried by the various inbred mouse 
strains can be typed with respect to their Ss and Slp type, as well as for the private H-2 anti- 
genic specificities controlled by the H-2K and H-2D loci of the H-2 complex, crossovers be- 
tween the H-gK and H-2D antigenic specificities can be localized with respect to the Ss-Slp 
complex.  The Ir-1  locus  (immune response to  branched, multichain, synthetic polypeptide 
antigens) is positioned in this schematic diagram on the basis of the results to be described in 
this paper. 
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FIG.  1.  From:  Klein, J., and  D. C. Shreffler. 1971. The  H-2 model  for  the  major histo- 
compatibility systems. Transplant.  Rev. 6:3. 
The  present  study  combines  two  methods  of  genetic  mapping:  (a)  the  de- 
termination  of  the  immune  response  to  branched,  synthetic  polypeptide 
antigens given by mouse strains bearing recombinant H-2 chromosomes derived 
from  intr~H-2  crossovers  between  chromosomes  of  known  tl-2  type  and 
known  immune  response gene type,  and  (b)  a  four-point linkage cross utilizing 
11-2,  tf  (tufted  hair  pattern),  T  (brachyury),  and  Ir-1  (immune  response  to 
branched,  multichain,  synthetic polypeptide  antigens).  The  results  show  that 
lr-1  maps  within  the  11-2  complex  lying  between  the  11-2K  locus  and  the 
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Materials  and Methods 
The  inbred  strains,  congenie  resistant  lines,  and  strains  which  are  not  inbred  but  are 
homozygous for known recombinant//-2 chromosomes are listed in Table I. 
The  antigens  used  in  this  study  were:  poly-L-(tyrosine,  glutamic  acid)-poly-DL-alanine-- 
poly-L-lysine  [(T,G)-A--L],  preparation  No.  509  (9);  poly-L-0aistidine,  glutamic  acid)-poly- 
DL-alanine--poly-L-lysine  [(H,G)-A--L],  preparation  Nos.  905  and  1201  (I0,  11);  poly-L- 
TABLE  I 
Strains Employed 
Strain  Synonym  H-2 Allele  Recombinant H-2 derivation* 
A/He  A  a  (K kD d) 
C3H.SW  CSW  b  -- 
C57BL/6  C57  b  -- 
BALB/c  --  d  -- 
C3H/He  C3H  k  -- 
C3H/DiSn  C3H  k  -- 
DBA/1  D1  q  -- 
A.SW  --  s  -- 
B10.A(1R)  --  h  (KaD b) 
B10.A(2R)  --  h  (KaD b) 
B 10.A(3R)  --  i  (KbD a  ) 
B 10.A(4R)  --  h  (KaD b  ) 
B10.A(5R)  --  i  (KbD a) 
H-2  °h  (not inbred)  oh  o  (KdD k) 
H-2  °z  (not inbred) ol  o  (KaD k) 
H-2  'a  (not inbred) al  a  (KkD a) 
H-2  a  (not inbred) tl  t  (KSD ~1) 
H-2  th  (not inbred) th  t  (KSD  a) 
AQR  (not inbred)  y  (KqD a) 
Linkage stock 
(Dr.  M.  Green)  (not inbred)  q  -- 
T(2:9) 138Ca  T138  q  -- 
* The notation used here follows the recent relocation of the centromere in the IXth mouse 
linkage group  (see references 16-18). 
(phenylalanine,  glutamic  acid)-poly-DL-alanine--poly-L-lysine  [(Phe,G)-A--L],  preparation 
No. 223  (11). 
Mice were immunized with 10 #g of (T,G)-A--L 509; 100/zg of  (H,G)-A--L  1201; 10 #g of 
(H,G)-A--L  905;  or  100 #g  of  (Phe,G)-A-L  223  emulsified  in  complete  Freund's  adjuvant 
(CFA)  and injected in the hind footpads as described previously (9-11). A  second injection of 
the same amount of the same antigen dissolved in phosphate-buffered isotonic saline, pH  7.4 
(PBS), was given in the hind footpads 3 wk later. Serum for antibody titrations was obtained 
by tail vein bleeding 10 days after the secondary stimulus (9-11). 
Antibody  response  was  measured  by  an  antigen-binding assay  (2)  in which  (T,G)-A--L 
labeled with  12sI  (2), or  (H,G)-A--L  or  (Phe,G)-A--L  labeled with acetic  anhydride-3H  (11) 
was  mixed with appropriate  dilutions  of mouse  antisera.  After  incubation,  labeled  antigen 
bound to antibody was precipitated  by the addition of appropriate dilutions of a  polyvalent 1262  GENETIC  MAPPING  OF  THE  IMMUNE  RESPONSE-I  LOCUS 
rabbit anti-mouse "y-globulin (2).  Results were expressed as per cent of antigen bound at a 
specific antiserum  dilution. 
Mice were maintained in standard plastic cages, on wood shavings, and were fed Purina 
laboratory chow or breeder chow (Ralston Purina Co., Inc., St.  Louis,  Mo.), as indicated. In 
the four-point linkage test, initial mating pairs were set up between mice of the A.SW strain 
:and mice carrying a special set of markers in the IXth mouse linkage group. These latter mice 
were kindly supplied by Dr. Margaret C. Green, The Jackson Laboratory, Bar Harbor, Maine. 
The A.SW strain is wild type  (3-)  for the  T  (brachyury)  and  tf (tufted hair pattern)  loci, 
carries the H-2" allele, and is a  low responder to  (T,G)-A--L, (H,G)-A--L, and  (Phe,G)-A--L. 
The A,SW genotype is thus 3-  3- H-28 Ir-1 (T,G)-low,  (H,G)-low,  (Phe,G)-low/_L  3-  H_~S 
Ir-J (T G)- low,  (tI,G)- 1  ow,  (Phe,G)- Iow.  The  linkage  testing  stock  mice  supplied  by  Dr. 
Green were of the following genotype: T  tf H-2 q Ir-1 (T,G)_ io w,  (H,G)- lo w.  (Phe, G) -Mgh/3- 
tf H-2q Ir-1 (T,G)-low,  (It,G)-low,  (Phe,G)-lMgh 
In such a cross, 50% of the offspring will receive the T allele and will be short-tailed, while 
50% will be wild type at the T locus. Short-tailed (T) F1 animals were used for the backcross 
T  t/  H-2~  3-  3-  H-2* 
I  I  I  I  i  I 
X 
I  I  i  I  i  i 
+  +  H-2  ~  +  +  H-2, 
FIG.  2. Ir-P mapping cross. Modified from: McDevitt, H. O., D. C. Shreffler, G. D. Snell, 
and  J.  H.  Stimpfling.  1971.  In  Immunogenetics of  the  H-2  System,  Symposium,  Liblice- 
Praha,  1970.  S. Karger, AG, Basel. 
H-2q  =  high response to  (Phe,G)-A--L 
H-2  ~ =  low response to  (Phe, G)-A--L 
to A.SW. The genotypes used in the backcross are shown in Fig. 2. The locallization of the It-1 
locus is not shown in this diagram, since this is the locus to be mapped. The It-1 genotype of 
the input parental chromosomes is given above and in Fig. 2. In brief, the H-2 ~ allele is linked 
to  high  response  to  (Phe,G)-A--L,. while  the  H-2 ~  allele  is  linked  to  low  response  to 
(Phe,G)-A--L. 
All parental, F1, and A.SW mice, as we]I as their offspring, were ear-tagged as soon as this 
was feasible. The offspring from this backcross were scored by inspection for the presence or 
absence of the T allele. This trait has approximately a 90% penetrance (6), so that about  10% 
of the animals bearing the T  allele would be missed. Offspring were scored for the tf allele by 
crossing them to the original linkage stock, since tf is a  recessive gene. In the event that no 
tufted offspring were obtained, crossing to the original linkage stock was continued wherever 
possible until at least eight offspring had been obtained. If none of eight offspring exhibited the 
tufted hair pattern by  12 wk of age, then the animal under test was scored  +/+  at the tf 
locus. H-2 typing was carried out by hemagglutination, using the polyvinylpyrrolidone method 
(12). The presence of antigens specified by the H-2 q chromosome was detected by the following 
antisera: 
(a)  AS-348D (B10.A[SR] X LP.R lII F1) anti-DBA/1 
Principal specificities: 17 and 30; 
(b)  C-13  (B10.BR)<  129)F1 anti-B10.AKM 
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(c)  AS-411B  (A.SW)< DBA/2)F1 anti-DBA/1 
Principal specificities:  25 and 30; 
(d)  AS-360 SJL anti-DBA/1 
Principal specificities:  25 and 30. 
The presence of H-2 antigens specified by the H-2 s allele were detected by the following anti- 
serum: 
AS-338D  (B10.Y  X WB.Re)F1 anti-A.SW 
Principal specificities:  1, 3, 19. 
Scoring for Ir-1 (Phe,G)-low or Ir-1 (Phe,G)-high was done by immunizing mice with (Phe,G)- 
A--L in CFA, followed  by a  booster injection of (Phe,G)-A--L in PBS, as  described above. 
Antibody response to (Phe,G)-A--L  was determined as described above. 
As indicated in the Results section, all animals which appeared to be recombinants between 
H-2 and Ir-1 were subjected to progeny testing. Those animals which, on progeny testing, ap- 
peared to be true recombinants between H-2  and It-1  were subjected to further analysis of 
their H-2 type by serologic testing (13, 14) and F1 skin graft testing (15). The antisera used for 
serologic testing of H-2 type, and the strains used for the F1 skin graft test are given in the 
Results section. 
RESULTS 
Localization of the lr-1 Locus by Determination of the Ir-1 Phenotype of Mouse 
Strains  Bearing  Recombinant  H-2  Alleles.- 
Recombination between the H-2K and H-2D loci of the H-2 complex occurs with sufficient 
frequency (about 0.5%)  to be detected in relatively small numbers of potential recombinant 
mice (on the order of 100-1000 animals). By appropriate crosses between inbred mouse strains 
of known H-2 type, F1 heterozygotes can be produced and backcrossed to either parental 
strain. In the backcross population, one-half of the animals will be heterozygous at the H-2 
complex, identical to the F1 parent in the backcross. The offspring of such an F1 X parent cross 
can then be tested for the presence or absence of H-2 antigenic specificities controlled by the 
H-2K and H-2D loci of the H-2 complex. For example, an H-2a/H-2 b heterozygote is crossed 
with an H-2b/H-2 b homozygote. Offsprihg are tested serologically  for possession of the H-2K 
and  H-2D  specificities  of the H-2 a  chromosome. Animals which lack  either the H-2K a  or 
H-2D a specificities are then subjected to progeny testing, serologic analysis, and are tested for 
their ability to absorb in vivo antisera of known H-2 antigenic specificity. When a proven re- 
combinant is detected, the recombinant H-2 chromosome can then be put on a known inbred 
mouse strain background by serial backcrossing, followed by an intercross and selection of the 
animals that are homozygous for the recombinant H-2 chromosome. 
In the present study, inbred and partially inbred mouse strains homozygous 
for known recombinant H-2 chromosomes were utilized in an attempt to localize 
the Ir-1 locus with respect to the H-2K and H-2D loci.  For example,  all mice 
of  the  H-2a/H-2  ~ genotype  are  low  responders  to  (T,G)-A--L  and  high  re- 
sponders  to  (H,G)-A--L, while  all  mice of the  H-2b/H-2  b genotype are  high 
responders to  (T,G)-A--L and low responders to  (H,G)-A--L. By immunizing 
mice homozygous for  recombinant H-2  chromosomes derived from  a  known 
crossover event between H-2  ~ and H-2  b,  we can expect to determine whether 
the It-1  phenotype is identical with  that  of the donor of the H-2K  or H-2D 
locus of the recombinant H-2 chromosome. It must be emphasized that such 1264  GENETIC  MAPPING  OF  THE  IMMUNE  RESPONSE-1  LOCUS 
studies  do  not  necessarily give  a  precise  localization of  the  Ir-1  locus,  but 
would simply indicate whether the Ir-1  locus is in the interval between H-2K 
and the  centromere, or in the interval between H-2D  and the telomere  (the 
noncentromeric end of the chromosome).2 
Thus,  the  initial aim  of  determining the  Ir-1  genotype of  the  known re- 
combinant H-2 chromosomes was simply to localize Ir-1  in either the centro- 
meric or noncentromeric part of the IXth mouse linkage group, using the two 
loci of the 11-2 complex as the division point. 
The  availability of  the  Ss-Slp  genetic  markers  permits  localization of  a 
known crossover event between the H-2K and H-2D loci of the H-2 complex, 
so  that  a  crossover can be  shown to have occurred between the  11-2K  locus 
and the Ss locus, or between the Ss locus and the H-2D locus. 
In utilizing recombinant H-2 chromosomes to localize the Ir-1  locus in the 
IXth mouse linkage group,  a  number of  assumptions have to be made.  The 
first is that the event giving rise to the recombinant 11-2 chromosome is a single 
crossover,  and that crossing over did not occur elsewhere in the IXth mouse 
linkage group.  The  second  assumption is  that  crossing  over  is  preceded  by 
homologous pairing and does not involve either duplication of certain segments 
of the chromosome, or  deletion of segments of one of the input chromosomes. 
The third  assumption is  that  the  Ir-1  locus controlling immune response to 
(T,G)-A--L,  (H,G)-A--L, and  (Phe,G)-A--L is  either  a  single locus  or  three 
very  closely linked loci,  and that  the  crossover  event giving rise  to  the  re- 
combinant 11-2  chromosome did not occur at or between these closely linked 
loci. These assumptions are implicit in using the recombinant 11-2 chromosomes 
to localize any genetic trait in the IXth mouse linkage group, and while some 
of them can be verified, as will be seen below, others must reraain assumptions 
which, although likely to be correct, are extremely difficult to prove. 
The It-1  phenotype was determined for  11  recombinant 11-2  chromosomes 
derived from crossovers between the H-2K and H-2D loci of known 11-2 chromo- 
somes with known Ir-1 genotype. Five of these 11-2 recombinants were derived 
from crossovers between H-2  ~ and 11-2 b by Stimpfling (19, 20). Three of these 
recombinant 11-2  alleles were derived from crossovers between H-2  d and 11-2 k 
(21). One each of the recombinant H-2 chromosomes derived from: (a) a cross- 
over between 11-2 a and H-2  ~ (20);  (b)  a  crossover between an artificially pro- 
2  The map positions for the H-2K and H-2D loci have been reversed from those referred to 
in previous publications, for example, see reference 3. This is due to a new finding (16-18) 
which places the centromere at the H-2K end of the H-2 complex. In standard genetic prac- 
tice, genetic markers are ordered from left to right, beginning with the centromere. Therefore, 
the map order of the IXth mouse linkage group is that given in Fig. 1. While this rearrange- 
ment is necessary to conform to standard practices, it may lead to confusion, since in earlier 
references to the localization of Ir-1  with respect to the H-2 complex, the H-2K region was 
designated as the right-hand, and the H-2D region as the left-hand ~)art of the H-2 complex. 
Throughout this paper, the new convention has been followed. McDEVITT,  DEAK~  SItREFFLER,  KLEIN~  STIMP~'LING,  SNELL  1265 
duced (by crossover) 11-2  ~ (11-2  ~-s*z, or 11-2  ~z) andH-2" (21); and (c) a crossover 
between//-2 ~ and 11-2q  (15). 
Table  II  gives  the  detailed  results  of  studies  of  the  immune  response  of 
strains  bearing  11-2  chromosomes  recombinant  between//-2 ~ and  H-2  b.  The 
TABLE II 
Immune Response  of Strains Bearing  H-2 Chromosomes Recombinant  Between  H-2  ~ and  H-2  b 
Strain  H-2  Crossover  Serum  used for  Type  diagram*  Immunizing antigen  No. of  %  Antigen bound  Antigen 
mice  Range  Average  dilntion~  titration§ 
A  a  --  (T,G)-A--L 509  9  5-15  10  1/500  509 
A  a  --  (H,G)-A--L 1201  8  61-83  77  1/10  1201 
A  a  --  (Phe,G)-A--L 223  10  73-76  75  1/10  223 
C3H.SW  b  --  (T,G)-A--L 509  20  46-84  71  1/500  509 
C3H.SW  b  --  (H,G)-A--L 1201  8  0-13  <5  1/I0  1201 
C3H.SW  b  --  (Pbe,G)-A--L 223  6  70-74  73  1/10  223 
C57BL/10  b  --  (T,G)-A--L 509  9  21-64  42  1/500  509 
C57BL/10  b  --  (H,G)-A--L 905  10  0-19  <5  1/I0  905 
C57BL/10  b  --  (Phe, G)-A--L 223  10  67-70  69  1/10  223 
B10.A  (1R)  h  K s  Ss  a ~ D b  (T,G)-A--L 509  11  0  0  1/500  509 
I  i 
B10.A  (2R)  h  K a  S~  a  ] D b  (T,G)-A--L 509  13  0  0  1/500  509 
i 
B10.A  (3R)  i  K b ! Ss  a  ' D s  (T,G)-A--L 509  13  19-75  46  1/500  509 
I  i 
BI0.A  (4R)  h  K a  ~ S~  b  D b  (T,G)-A--L 509  9  ~5-22  5  1/500  509  ,, 
i 
B10.A (4R)  h  K s  ~ Ss  b  D b  (H,G)-A--L 905  9  68-74  71  1/10  905 
i  t 
i 
B10.A  (4R)  h  K a  ~f Ss  b  D b  (Phe, G)-A--L 223  6  42-58  53  1/500  5091[ 
i  I 
BI0.A (5R)  i  K b ! SlsS  D a  (T,G)-A--L 509  9  32-57  43  1/500  509 
b  '~ Ssa  D a  (H,G)-A--L 905  5  0-20  6  1/10  905  BI0.A (5R)  i  K  ,, 
, 
* The notation  used here follows the recent relocation  of the centromere  in the IXth mouse linkage group 
(references 16-18). 
Dilutions for (H, G)-A--L 905 and 1201 and  (Phe,G)-A--L 223 were 1/10 to give equimolar amounts of anti- 
gen and antiserum with respect to the assay for (T,G)-A--L 509  (1/500 serum dilution). 
§ (H,G)-A -L 905 and 1201 gave equal %  antigen-bound values in this assay. In addition,  both elicited identi- 
cal  immune responses in  high-responder  and  low-responder  stiains  (McDevitt,  H.  O.,  and  E.  Mozes.  Unpub- 
lished data). 
II In a  few instances,  the extensive cross-reactions  between antisera to these antigens were utilized  to  titer 
antisexa to  (H,G)-A -L or (Phe, G)-A--L after the supply of  905-3H,  1201-3H,  and  223-3H  were exhausted  (refer- 
ence 23). 
immune  response  characteristic  of  all  strains  bearing  the  two  parental  chro- 
mosomes, 11-2  ~ and H-2  b,  is shown in the top part of the table.  The remainder 
of the  table  lists  the five tt-2  recombinants  derived  from crossovers between 
//-2  ~ and 11-2  b (19,  20).  In the  schematic  crossover diagram  for each  of the 
11-2 recombinant  alleles,  the donors of the 1t-21£  and 11-2D  loci are indicated 
by a  or b.  The  Ss  locus  is  positioned between  the  1=1-21£ and  11-2D  loci. The 
position of the crossover giving rise to the recombinant  11-2  allele  is indicated 1266  GENETIC  3,~.PPING  O1  v  THE  IMMUNE  RESPONSE-1  LOCUS 
by the  dotted line,  and was deduced from determining  the  Slp  genotypes of 
the H-2 recombinants (8).  Comparison of the immune response to (T,G)-A--L, 
(H,G)-A--L, and (Phe,G)-A--L, of strains bearing the parental H-2  ~ and H-2  b 
chromosomes, with  the immune response of strains  bearing the H-2 recombi- 
nants  (H-2  h  and  H-2i),  shows  that  in  all  cases  the  strains  bearing  the  H-2 
recombinants respond to these antigens in the same way as do the donors of the 
H-2K locus,  or centromeric part of the recombinant H-2 complex. Therefore, 
on the basis of these results,  and the assumptions listed  above, the Ir-1  locus 
is localized to the centromeric or H-2K region of the H-2 complex. 
TABLE  III 
Immune Response  of Strains Bearing H-2 Chromosomes Recombinant  Between H-2  a and H-2  k 
Strain  H-2  Crossover 
type  diagram* 
Antigen  Immunizing antigen  No. of  %  Antigen bound  Serum  used for 
mice  Range  Average  dilution:~  titration§ 
BALB/c  d  --  (T,G)-A- L  509  8  0-55  28  1/500  509 
BALB/c  d  --  (H,G)-A--L 1201  10  15-63  42  1/10  1201 
BALB/c  d  --  (Phe, G)-A--L 223  9  68-75  72  1/10  223 
C3H  k  --  (T,G)-A--L 509  10  8-46  19  1/500  509 
C3H  k  (H,G)-A--L 905  8  61-82  71  1/10  1201§ 
C3H  k  --  (Phe,G)-A--L 223  10  72-75  74  1/10  223 
H-2  °-SSl  o I  K d  I Ss  k  D k  (H,G)-A--L 905  25  <8-6o  32  1/10  905 
i  lJ  i 
H-2°-Ss~  °h  I---K  d  SlSd tiDk_  ~p  (H,G)-A -L 905  14  6-58  32  1/10  905 
1t_2o-8,  ~'  o h  ~K  d  Slsd II D k  I  (H,G)-A--L 905  12  0-43  20  1/10  905 
H-2  "-S~l  a t  K k  Ss  k  ~d D d  (H,G) A  L  905  13  67-76  72  1/10  905 
I  I  i  I 
i 
* The  notation  used here  follows  the  recent  relocation  of the centromere  in  the IXth mouse linkage group 
(references  16-18). 
Dilations for  (H,G)  A--L 905 and  1201 and  (Phe,G)-A--L 223 were 1/10 to give equimolar amounts o{ anti 
gen and antiserum with respect to the assay for (T,G)-A--L 509  (1/500  serum dilution). 
§  (H, G)-A--L 905 and 1201 gave equal ~  antigen-bound values in this assay. In addition,  both elicited identi 
cal  immune  responses  in  high-responder  and  low responder  strains  (McDevitt,  H.  O.,  and  E.  Mozes.  Unpub 
lished  data). 
The  immune  response  of  strains  bearing  H-2  chromosomes  recombinant 
between H-2  '~  and H-2  k are shown in Table III. As in Table II, the top part 
of the table lists the details  of the immune response characteristic of all H-2  e 
and H-2  ~  strains of mice. The bottom part of the table lists the H-2 recombinants 
borne by the strains  tested,  a  schematic diagram of the crossover, similar  to 
that  in  Table  II,  and  the  immune  response  of these  strains  to  the  antigens 
tested.  Once again,  comparison of the immune response of the parental  H-2  ~ 
and  H-2  ~:  strains  with  the  immune  response  of the  H-2  recombinant strains 
shows that in each case the recombinant strain responds to (H,G)-A--L in the 
same  manner  as  does  the  donor  of  the  centromeric  or  H-2K  region  of  the 
recombinant chromosome. 
These  results  once again indicate  that  It-1  maps  in  the  centromeric  (left- McDEVITT, DEAK, SHREFFLER, KLEIN, STIMPFLING, SNELL  1267 
hand)  part  of  the  IXth  mouse linkage  group,  either  in  the  K  region  of the 
II-2 complex, or somewhere to the left of the H-2 complex. Because of a shortage 
of animals, and because the parental H-2  d and H-2  k strains differed only in their 
immune response to  (H,G)-A--L, the  mouse strains bearing the H-2  recombi- 
nants  were tested only with this  antigen.  If the  assumptions given above are 
correct, one would expect all the H-2 recombinants in Table III to give a low 
or variable response to (T,G)-A--L, and a high response to (Phe,G)-A--L. This 
assumption is currently being tested. The results as given in the table are con- 
sistent in that strains bearing the H-2  d chromosome give a medium and variable 
response  to  (H,G)-A--L,  while  strains  bearing  the  H-2  k  chromosome give  a 
uniformly high response to (H,G)-A--L. 
Table IV gives the immune response of strains bearing recombinants between 
H-2  ~' and H-2  ~ and It-2  ~ and H-2q. The immune response of strains bearing the 
parental  H-2  chromosomes is given in the  appropriate positions in  the  table. 
The results given in  this  table  differ from  those given in Tables II  and  III 
for two out of the three recombinants listed in Table IV. 
The recombinant H-2 tz gives a low response to (T,G)-A-L, a high response 
to  (H,G)-A--L,  and  a  high response  to  (Phe,G)-A--L.  This is similar to  the 
immune response of strains bearing  the  H-2  ~ or the  II-2  ~'z recombinant listed 
in  Table  III.  Since  strains  bearing  H-2  ~ are  low  responders  to  (T,G)-A--L, 
(H,G)-A--L,  and  (Phe,G)-A--L,  this  indicates  that  the  IXth  mouse  linkage 
group  bearing  H-2 tz  responds  as  does  the  donor  of  the  right-hand, 
noncentromeric,  (It-2D),  region of the H-2 complex. It should be pointed out 
that the crossover in this case is localized to the left of Ss between the H-2K 
locus of H-2  ~ and the H-2D locus of H-2  ~'z. These results are in contrast to those 
given by mice bearing the H-2 th recombinant derived from a crossover between 
H-2" and H-2  ~', with the crossover occurring to the right of Ss, between the Ss 
locus and the H-2D  locus of H-2  a. Mice bearing this H-2 recombinant respond 
in a  manner similar to mice bearing the H-g"  allele, once again localizing Ir-1 
to the left of the crossover in either the centromeric part of the II-2 complex 
or of the IXth mouse linkage group. 
Using  the  assumptions  listed  above, the  response of the  two  recombinant 
H-2 t alleles can be interpreted in one of two ways. The first is that the crossover 
giving rise to the H-2 tz recombinant is farther to the left within the H-2 complex 
than  any of the  other  crossovers tested,  and  the  fact that  mice bearing  this 
chromosome respond as does the donor of the noncentromeric part of the H-2 
complex indicates that It-1 is localized between the H-2K  locus of H-2 and the 
Ss locus. Since the H-2 tt~ recombinant was derived from a crossover that occurred 
to the right of Ss, it is to be expected that mice bearing this chromosome would 
respond as do mice bearing the H-2" chromosome. The alternate explanation is 
that the H-2 a recombinant is the result of a double crossover event and that the 
assumptions listed above are incorrect in this respect. 
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studies  of the immune  response  of mice  bearing  the  recombinant  H-2y  chro- 
mosome derived from a  crossover between I-I-2q  and H-2  ~.  This recombinant, 
H-2  v, is known to be derived from a  single crossover event  (15) because one of 
the  parental  IXth mouse linkage groups involved in the  crossover event had 
TABLE  IV 
Immune Response  of Slrains  Bearing  H-2 Chromosomes  Recombinant Belween 
H-2  ~ and H-2" or H-2" and H-2q 
Strain  H-2  Crossover  Serum  Type  diagram*  Immunizing antigen  No. of  %  Antigen bound  Antigen 
mice  Range  Average  dilution~  used for  titration§ 
A  a  --  (T,G)-A -L 509  9  5-15  10  II500  509 
A.  a  --  (H,G)-A--L 1201  8  61-83  77  1/I0  1201 
A  a  --  (Phe,G)-A--L 223  10  73-76  75  1/10  223 
A.SW  s  --  (T,G)-A--L 509  6  0  0  1/500  509 
A.SW  s  --  (H,G)-A--L 905  6  0  0  1/10  905 
A.SW  s  --  (Phe, G)-A-L 223  6  <5-27  15  1/10  223 
H-2  ¢-8.l  t I  KS~  Sisal  D sl  (T, GJ-A--L 509  5  <5  <5  1/500  509 
H-2  t-8*l  t I  K s ~l Ss  s!  D al  (H,G)-A--L 905  13  67-72  70  1/10  905 
I 
i 
H  2  t-s'~  t]  KS I Sisal  Da!  (Phe,G)-A--L 223  12  8-69  41  1/500  509!1 
H2  t-Bah  t h  K s  S  s s  [ D s  (H,G)-A--L 905'  8  0  0  1/10  905 
! 
t 
DBA/I  q  --  (T,G)-A--L 509  10  0  0  1/500  509 
DBA/1  q  --  (H,G)-A--L 1201  10  0  0  1/10  1201 
DBA/I  q  --  (Phe,G)-A--L 223  10  69-76  74  1/10  223 
AQR  y  K q  Ss  s  D ~  (T,G)-A--L 509  6  0  0  1/500  509 
I 
AQR  y  K q  Ss  ~  D a  (H,G)-A--L 905  3  55-60  57  1/10  905  q 
AQR  y  K q  Ss  s  D a  (H,G)-A--L908  6  36-49  45  1/500  905  I 
I 
AQR  y  K q  Ss  s  D ~  (Phe,G)-A--L 223  3  61-67  64  1/10  223  I 
i 
AQR  y  K q  Ss  a  D a  (Phe, G)-A--L223  6  51-63  87  1/500  223 
* The notation used here follows the recent  relocation of the centromere in the IXth mouse linkage group 
(references  16-18). 
Dilutions for (H,G)-A--L 905 and 1201 and (Phe,G)-A--L 223 were 1/10 to give equimolar amounts of anti- 
gen and antiserum with respect to the assay for (T,G)-A--L 509 (1/500 serum dilution). 
§ (H,G)-A--L 905 and 1201 gave equal % antigen-bound values in this assay. In addition, both elicited iden- 
tical immune responses in high-responder and Iow-responder strains (MeDevitt, H.  O.,  and E. Mozes.  Unpub- 
lished data). 
[1 In a few instances, the extensive cross-reactions between antisera to these three antigens were utilized to 
titer antisera to  (H,G)-A--L or  (Phe, G)-A--L after the supply  of 905-all,  1201-3H,  and  223-3H was  exhausted 
(reference 23). 
outside markers to the right (translocation 138, or T138) and left (T, brachyury) 
of the H-2q complex. These outside markers serve to establish  that  the initial 
crossover event was, in fact,  a  single crossover. The immune response of mice 
bearing//-2~  is similar  to that of mice bearing It-2  t~ in that it is characteristic 
of the donor of the II-2D  locus of the II-2 complex.  Thus,  the H-2  ~ mice are McDEVITT, DEAK, SHREFFLER, KLEIN, STIMPFLING, SNELL  1269 
low  responders to  (T,G)-A--L, high  responders  to  (H,G)-A--L, and high  re- 
sponders to (Phe,G)-A--L. On the other hand, mice bearing H-2q (T138,DBA/I) 
are high responders only to (Phe,G)-A--L. Mice bearing the H-2y recombinant 
respond well to both (H,G)-A--L and (Phe,G)-A--L, as do H-2  ~ mice. Since this 
crossover maps between the H-2K  locus of H-2 and the Ss locus, It-1  must be 
a  property of  the  donor of  the  centromeric (or right-hand) part  of  the  H-2 
complex. Furthermore, since this crossover involved a single exchange, it must 
be concluded that It-1  maps between H-2K  and the Ss locus. 
TABLE V 
Res2dts of a Four-Point Cross Designed to Map Ir-1 with Respect  to 11-2 
Recombinants  between  Number  Per cent  (Phe,  G)- A--L  response* 
H-2-  T  57  11.7 
H-2 -  tf  19  3.9 
See below 
Appropriate  14 
Inappropriate  2 
(No. 351, No. 489) 
tf -  T  22  4.5  Appropriate  20 
Inappropriate  0 
Not localized (infertile in  16  3.3  Appropriate  11 
scoring backcross)  Inappropriate  0 
Total number of backcross mice scored: 484  (see Fig. 2 for composition of this cross). 
* 10 known recombinant  mice were not immunized because they died during the long 
period required for scoring for tufted  (8-10 wk)  and for backcrossing several times to the 
tufted  linkage stock or to an inbred strain which is +/+  at the T locus. Previous testing 
established  that the T -  tf- H-2  q linkage stock responded to (T,G)-A--L; (H,G)-A--L and 
(Phe,G)-A--L in a manner identical to the DBA/1 strain. 
It should also be pointed out that H-2 a and H-2 th, derived from two separate 
crossover events, have been extensively analyzed (22) and shown to be identical 
for all the known serologic specificities possessed by either H-2  ~ or H-2  ~. Thus, 
these two recombinants appear at present to differ only at the Ss and Ir-1  loci. 
While these serological results must be verified by skin graft testing, they suggest 
that It-l,  like Ss (5), maps near the center of the H-2 complex, but is not itself 
a  transplantation antigenic specificity. 
Localization  of the  Ir-1  Locus  by Genetic  Mapping.- 
Independent verification of the localization of Ir-1 near the center of the H-2 complex be- 
tween H-2K and the Ss-Slp complex was obtained by a four-polnt linkage test. The genotype 
of the original linkage stock and the A.SW strain, as well as the genotype of the parents used in 
the test cross, was previously described (Materials and Methods, and Fig. 2). As outlined in the 
Materials and Methods section, offspring of the cross diagramed in Fig. 2 were scored with re- 
spect to T, t.f, and H-2. By determining the genotype of known recombinant mice, the cross- 1270  GENETIC  MAPPING  012  `  TIIE  IMMUNE  RESPONSE-1  LOCUS 
overs could be located either between T and if, or between If and H-2. In some cases, putative 
crossovers could not be progeny tested because of infertility. All  of the proven recombinant 
nfice were then immunized with (Phe,G)-A--L. Since the cross was on an A.SW background, 
(nonresponders to  (Phe,G)-A--L), recombinant mice bearing H-2 q would be expected to  be 
high responders to (Phe,G)-A--L, while recombinant mice lacking H-2 q would be expected to 
be lmv responders to (Phe,G)-A--L. 
TABLE  VI 
Immune Response  of Recombinant Mice fl'om Mapping Study  and  Their Progeny 
Reaction  with AS-348  Immune response to 
Animal No.  H  2 genotype  (anti  H-2.I7,30)  (Phe,G)-A--L* 
351  q/s  q-  0 
Backcross 1 
(351 ×  A.SW) 
716  s/s  --  0 
717  s/s  --  0 
718  s/s  --  0 
719  q/s  q-  0 
720  q/s  q-  0 
721  q/s  -k  0 
722  q/s  q-  0 
489  q/s  q-  12 
Backcross 1 
(489  X  a.SW) 
1122  s/s  --  N.T. 
1123  q/s  q-  N.T. 
1124  s/s  --  N.T. 
Backcross 2 
(1123  X  A.SW) 
1449  s/s  --  0 
1450  q/s  q-  0 
1451  q/s  q-  8 
1452  q/s  q-  N.T.  (mated) 
1453  s/s  --  0 
1454  q/s  +  0 
1455  q/s  q-  N.T.  (mated) 
1456  s/s  --  0 
1457  q/s  +  N.T.  (mated) 
* Mice immunized with (Phe,G)-A--L 223 and titered with (T,G)-A--L 509 at 1/500 serum 
dilution. 
Results  of  this  mapping  study  are  given  in  Table  V.  Of  484  offspring,  57 
(11.7%)  recombinants  between  Y  and  H-2  were  actually  detected.  This  is 
consistent  with  the  expected  frequenc  3  of  14%,  particularly  since  the McDEVITT,  DEAK,  SHREFJ~'LER,  KLEIN,  STIMP~FLING,  SNELL  1271 
heterozygous parents included both male and female mice. (The predicted rate 
of 14 % recombination is for females and is known to be lower in males.) Of the 
41  recombinants that  could be further localized,  approximately half occurred 
between  T  and  tf and  half between  tf and  H-2.  This  again  agrees  with  the 
expected equal frequencies of crossovers between these three loci predicted by 
the equal mapping distance  (seven map units)  between T  and tf and between 
If and//-2. As can be seen in the last column of Table V, two mice, which were 
derived from a  crossover between tf and//-2,  gave an inappropriate immune 
response to  (Phe,G)-A--L.  Both  of  these  mice  appeared  to  carry  the//-D 
chromosome and  were low responders to  (Phe,G)-A--L. Presence  of the H-D 
allele was established by reaction with  antiserum No. AS-348,  which  was ex- 
pected  to  have  as  its  principal  specificity H-2.17,  a  specificity  of  the  //-2K 
TABLE  VII 
Summary of Serological Data on  (No. 351  X  C3H.BIO)FI  Mice 
Test cell  H-2 type 
Anti-17  Anti-19  Anti-30  Anti-ll 
(B10.A X AKR)  (n2 ;<  (C3H.B10 X  (B10 X A) a-A.SW  BF) 
AKR.M) a-C3H.Q  a-AKR.M  a-CR 
CT~  HA§  CT  HA  CT  HA  HA 
351  )<  C3H.B10  rec/b  0*  0  80*  2560*  40*  640*  0* 
C3H.Q  q/q  160  160  0  0  40  320  80 
B10.S  s/s  0  0  160  640  0  0  0 
* Confirmed by in vivo absorption. 
:~ CT =  cytotoxic test. Reciprocal of highest dilution giving a positive result. 
§ HA =  hemagglutination. 
locus of the I-I-D complex, but probably also contains antibodies to H-2.30,  a 
specificity of the//-2D locus of//-D. 
Table VI shows  the  results  of progeny testing  of these two  animals  (Nos. 
351  and  489)  with  respect  to  the  presence  in  their  offspring  of  the  H-2.17 
specificity, and their immune response to  (Phe,G)-A--L. As can be seen from 
this table, both the reaction with AS-348 and a  low response to (Phe,G)-A--L 
were inherited in the progeny of these two animals. 
These  results,  of themselves,  suggested  recombination between  the  //-2K~ 
locus and the It-1 locus. Further characterization of this recombinant required 
testing recombinant animals for the presence or absence of the 11-21) specificities 
of the//-D complex. 
This was done by several serological tests and by F1 skin graft tests. Table 
VII is a  summary of the  serological data on offspring of recombinant no.  351 
(whose progeny testing was presented in Table VI). The antisera used and their 
specificities are shown in Table VII. The results are given as titers against test 
cells from the indicated sources in the cytotoxicity test or the hemagglutination 1272  GENETIC  MAPPING OF  THE  IMMUNE  RESPONSE-I  LOCUS 
test. Specificities H-2.17 and H-2.11  are specificities of the tI-2K  q allele. Spec- 
ificity 30 is  a  private specificity of the II-2D~ allele.  Specificity 19 is a private 
specificity of the H-2K"  allele. Table VII shows the results with the progeny 
of recombinant No. 351,  as well as with animals of the C3H.Q strain, which is 
congenic with C3H, but carries H-2~,  and the B10.S strain, which is congenic 
with C57BL/10, but carries H-2  ~. As can be seen, recombinant No. 351 lacks 
specificities H-2.17  and H-2.11  of the H-2Kq  allele.  These specificities appear 
to be replaced with specificity H-2.19 from the H-2K  ~ allele.  The No. 351 prog- 
eny do carry specificity H-2.30 from the H-2D~ allele.  Therefore, recombinant 
TABLE  VIII 
F1 Skin Graft  Tests of Recombinant No. 35i 
Mean 
Experi- Donor (H-2 type)  Recipient (1t-2 type)  Surviving  survival 










> 100  (C3H  X  DBA/1)F1  i0/i0 
(H-2k/H-gq) 
(C3H  X  (351 X  A.SW)BC)  0/16  12.7 
(I1-2k/11-2 s or H-2k/H-2 tee'*) 
(C3H.B10$  X  (351 X A.SW)BC)  0/24  11.1 
(H-2b/H-2 s or H-2b/H-2 .... ) 
(C3H.B10,)<  (351)<  A.SW)BC)  0/26  <14§ 
(11-2b/11-2 s or 11-2b/H-2 tee') 
* H-2 rec" is used to designate the H-2 recombinant allele of No. 351. 
:~ Several FI skin graft experiments (D. C. Shreffter,  unpublished data) have shown that 
C3H.B10 is entirely histocompatible with C3H and C3H.Q, except for the H-2 differences. 
§ All grafts were rejected by 14 days. 
No. 351  and its progeny appear to carry a IXth mouse linkage group with a 
crossover within the H-2 complex between the It-2K and tI-2D loci. As indi- 
cated by the  asterisks  in  Table VII,  the  specificities assigned  by serological 
testing were confirmed by in vivo absorption of the various anti-H-2 specificities 
in the respective antisera. 
In addition, progeny of recombinant No. 351 were subjected to an F1 skin graft test. In 
this test,progeny  of several backcrossed  generations, in which offspring of recombinant No. 351 
were successively backcrossed to A.SW, were crossed with C3H or C3H.B 10, a strain congenic 
with C3H, but carrying H-2 b. The progeny of this cross then c~rried H-2 b or 11-2 b in associa- 
tionwitheithertheH-2  recombinant  orH-28 from theA.SWline. All animalswere skin grafted 
with skin from C3H.Q animals, which are congenic with C3FI and C3H.B10,  except for the H-2 
complex, where they carry H-2 q. If the tt-2 chromosome in No. 351 is indistinguishable from 
11-2 q, then skin from the C3H.Q line should be accepted by the progeny of the cross [(351 )< 
A.SW)  backcross )< C3H or C3H.B10]. McDEVITT,  DEAK,  SHREFFLER,  KLEIN,  STIMPFLING,  SNELL  1273 
As  shown  in  Table VIII, in  three  separate series  of  tests  all  the  progeny 
rejected the C3H.Q skin grafts within 11.1-12.7  days. This is compatible with 
a  difference at the H-2 locus and indicates that the H-2~ specificities found in 
recombinant No. 351 are incomplete and do not represent an intact H-2~ allele. 
Thus, the results of both the serological tests and the F1 skin graft tests are 
concordant  in  showing  that  the  H-2  chromosome carried  by the  progeny of 
recombinant No.  351  lack the  H-2Kq  specificities,  and carry the H-2K  ~ spec- 
ificities.  This  means  that  the  initial  indication  of  recombination  between 
H-2q  and It-1  in  animal No.  35I  was actually due  to  a  crossover within  the 
H-2  complex.  This  result  is  thus  completely  consonant  with  the  results  of 
immunizing  animals  bearing  known  H-2  recombinants,  indicating  that  the 
Ir-1 locus is near the center  of the H-2 complex.  (Similar tests are currently 
being carried out on the progeny of recombinant No. 489 in an effort to establish 
T  tf  Kq (11,  17)  Ir-lq  D~ (30) 
t  I  I  I/__2 
J,  J  I  I 
+  +  K • (19)  It-l*  1> 
1 
+  +  K" (19)  Ir-l"  Dq (30) 
I  J  I  I  I 
FI6.  3.  A schematic diagram of the crossover event giving rise to  recombinant No.  351. 
This diagram is based on the data in Tables VII and VIII. 
that this animal also represents a crossover within the H-2 complex, rather than 
between H-2 and It-1.) This crossover is diagramed in detail in Fig. 3. 
DISCUSSION 
The results presented in this paper indicate that the It-1 locus,  controlling 
the quantitative immune response to a series of branched, multichain, synthetic 
polypeptide antigens,  maps within the H-2 complex, somewhere between the 
H-2K  locus controlling the K  set of histocompatibility  antigenic  specificities, 
and the Ss locus controlling  the level of a  serum alpha globulin  (see Fig.  1). 
The position of It-1 within the H-2 complex is indicated in the first place by 
the  results of immunizing strains of mice homozygous for 11  different known 
recombinant H-2 types. The crossovers giving rise to these H-2 recombinants 
occurred between the H-2K locus and the Ss locus, or between the Ss locus and 
the H-2D locus. The results with nine of the eleven H-2 recombinants indicated 
that  It-1 was to the left of the  crossover. Results with  two of the  eleven re- 
combinant H-2 chromosomes indicated that It-1 was to the right of the cross- 1274  GENETIC  MAPPING  OF TIIE IMMUNE  RESPONSE-I  LOCUS 
over. Both of these H-2 recombinants were derived from crossover events which 
took place between the H-2K locus  and the  Ss-Slp  locus.  Since one of these 
recombinants, H-2y, was derived from a known single crossover event (proven 
by outside markers to the left and right  of the H-2 complex), the  possibility 
that both of these recombinants were the result of a double crossover has been 
almost completely ruled out. 
The  results  of  the  four-point  linkage  test  are  entirely  consistent  with  the 
above conclusion.  In 484  offspring,  only two  putative recombinants between 
H-2 and Ir-1 could be detected. Although there is a possibility that this cross- 
over incidence is slightly low (due to the  10%  failure of penetrance of the  T 
allele),  it must be noted that  a  recombination rate of 0.4%  between H-2 and 
Ir-1 is of the order of magnitude previously established for crossover frequencies 
within the H-2 complex. Of the two putative crossovers between H-2 and It-l, 
extensive testing  of mouse No.  351  has  established  the  event  as  a  crossover 
within  the  H-2  complex  in  which  the  recombinant  chromosome  carries  the 
I1-2K  specificities of H-28  and the H-2D locus of H-2q.  This recombinant H-2 
chromosome is thus similar to nine of the eleven previously tested H-2 recom- 
binants in indicating that It-1  is  associated  either  with H-2K  or  the  centro- 
meric part  of  the  chromosome. The  second  tentative  recombinant  between 
H-2  and  It-1  is  currently being tested. 
Since it is now clear that there  are  a  great many histocompatibility-linked 
specific immune response genes (3), the significance of the finding that one of 
these  genes,  It-l,  maps  within  the  H-2  complex  must  be  considered.  The 
nature of the relationship between H-2 and Ir-1 must also be considered in the 
light  of  possible  mechanisms  of  gene action  of  the  histocompatibility-linked 
specific  immune  response  genes.  This  subject  has  been  discussed  in  detail 
elsewhere (3)  and will not be repeated here, except to point out that the pres- 
ently  available evidence  suggests  that  immune  response  genes  affect antigen 
recognition, perhaps at the level of thymus-derived, antigen-reactive lympho- 
cytes, or possibly at the level of both thymus-derived and bone marrow-derived 
(antibody-forming  precursor)  lymphocytes.  Since  Ir-1  maps  inside  the  H-2 
complex, it is logical to consider whether this gene(s) controls some cell surface 
structure  which  is responsible for antigen recognition by one or several types 
of immunocompetent cellsJ 
3 It should be pointed out that Ir-1 probably does not represent an  immunoglobulin vari- 
able region gene because it has been shown previously (23) that It-1 is not linked to the mouse 
immunoglobulin allotypes (which are localized  in the heavy chain constant region linkage 
group), and  because of the findings in rabbits  (Prahl, J.  W.,  W. J.  Mandy,  G.  S.  David, 
M. W. Steward, and C. W. Todd. 1970. Participation of allotypic markers in rabbit immuno- 
globulin classes.  In  Protides of the Biological  Fluids  (XVIIth Colloquium), Bruges,  1969. 
Pergamon Press Ltd., Oxfordi England. 125-130.) that the heavy chain constant and variable 
region are genetically linked. This does not rule out the possibility that Ir-I represents a light 
chain variable region gene. The latter possibility seems less likely, since a  major part of the 
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In the present state of our knowledge, the possible relationship between 11-2 
and It-1  can be broken into two broad categories. The first is that Ir-1 repre- 
sents  some  type  of  chemically  specific  interaction  between  H-2  antigenic 
specificities and classical immunoglobulin receptors on the surfaces of immuno- 
competent cells.  The second possibility is that It-1 is completely unrelated to 
the H-2 complex but maps in the same part of the IXth mouse linkage  group 
because it controls some other cell surface structure which is intimately involved 
with specific antigenic recognition. If this is  the case,  the nature  of the It-1 
gene product must at the present time remain a matter of speculation. However, 
further mapping  studies designed to localize the  other H-2 linked specific re- 
sponse genes within the IXth mouse linkage group in general, and within the 
11-2 complex in particular,  can be of considerable value in differentiating be- 
tween these two broad categories of possible explanations for the mechanism of 
action of the specific immune response genes. 
If the first explanation given above is correct, one would expect that different 
immune  response genes would be  a  property of different I-I-2 antigenic spec- 
ificities,  and  that  therefore separate immune response genes would map with 
the H-2K locus, or with the H-2D locus. On the other hand, if the second pos- 
sibility is correct, and the specific immune response genes are the result of a 
separate  and  distinct  antigenic  recognition  system,  possibly  unrelated  to 
immunoglobulin, then one might expect them all to map in the same narrow 
region between H-2K and Ss-Slp,  or possibly between H-2K and 11-2D. Since 
there are now a large number of antigens under this type of histocompatibility- 
linked genetic control, mapping studies analogous to the ones presented here 
could provide a basis for a tentative choice between the two alternatives given 
above. 
A second approach to the resolution of this choice could be provided by the 
detection of two  recombinant H-2 chromosomes which were histocompatible 
but differed at the Ir-1 locus. (A systematic search for such differences among 
the known inbred strains  bearing known 1t-2  alleles has  been unproductive 
[see  reference 1].)  As mentioned above, the 11-2  t~  and the 11-2  th recombinant 
alleles appear,  by serologic testing,  to fulfil these criteria. Definitive proof of 
this possibility will  require the production of congenic strains which carry the 
two  recombinant  alleles on  an identical genetic background,  after which  re- 
ciprocal exchange of skin grafts will  prove identity or nonidentity of the re- 
combinant H-2 alleles. 
There is tentative evidence to suggest that the second of the two possibilities 
presented above is the correct one. Bailey (24) has shown that the genetic con- 
trol of the ability to reject the Y transplantation antigen is associated with the 
centromeric, or H-2K,  region of the H-2 complex. Lieberman (25)  has shown 
that the genetic control of the ability to produce anti-3'A allotype antibody is 
also a property of the K region of the 11-2 complex. Finally, Merryman (personal 
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synthetic  polypeptide  GAT10 is  also  a  property  of  the  K  region of  the  H-2 
complex. Vaz et  al.  (26)  have  also  shown that  the  ability  to respond to low 
doses of ovomucoid and bovine 3'-globulin is a property of the K  region of the 
H-2 complex. In each of these cases,  localization was accomplished through the 
use  of  H-2  recombinants  produced  by  Stimpfling  from  crossovers  between 
H-2  '~ and H-2  b. These results are identical  to those given with  (T,G)-A--L and 
(H,G)-A--L, and suggest that for the five different specific  immune response 
genes  so far  tested,  all  appear  to be localized to the  same part  of the  IXth 
mouse linkage group, and therefore,  presumably, to the same part of the H-2 
complex.  A  definitive  answer  to this  question  will require  completion of the 
mapping studies for the specific  immune response genes already listed  above, 
and extension of these studies to several other specific immune response genes 
linked to the H-2 complex. If these results indicate that the immune response 
genes all  map between the H-2K locus and the Ss-Slp  complex, the nature of 
the  gene  product  controlled  by a  locus such  as  It-1  remains  a  problem  for 
further investigation. 
:Vote Added in Pro@--Serologic analysis of the second recombinant  between  H-2 
and Ir-I  (No. 489) in the mapping study has shown that this recombinant  H-2 chro- 
mosome has specificity 19 from H-2  s and  specificity 30 from H-2q. This  recombinant 
chromosome is thus similar to recombinant No. 351, as would have been predicted." 
SUMMARY 
Eleven strains of mice bearing recombinant H-2 chromosomes derived from 
known  crossover  events  between  known H-2  types  were  immunized  with  a 
series  of  branched,  multichain,  synthetic  polypeptide  antigens  [(T,G)-A--L, 
(H,G)-A--L, and  (Phe,G)-A-L]. Results with nine  of the  eleven H-2  recom- 
binants indicated that the gene(s)  controlling immune response to  these  syn- 
thetic  polypeptides  (It-l)  is  on the  centromeric or H-2K  part  of the  recom- 
binant  H-2  chromosome.  Results  with  two  of  the  eleven  recombinant  H-2 
chromosomes indicated  that  It-1  was  on the  telomeric  or H-2D  part  of the 
recombinant H-2 chromosome. Both of these recombinants were derived from 
crossovers between the H-2K locus and the Ss-Slp locus near the center of the 
H-2 region. One of these recombinants, H-2  ~, was derived from a known single 
crossover event. These results indicate that Ir-1 lies near the center of the H-2 
region between the H-2K locus and the Ss-Slp locus. 
The results of a four-point linkage test were consistent with these results. In 
484 offspring of a cross designed to detect recombinants between 1t-2 and Ir-1, 
only two  putative  recombinants  were  detected.  Both  of these  recombinants 
were  confirmed by progeny  testing.  Extensive  analysis  of  one  of  them  has 
shown that the crossover event occurred within the H-2 region. (Testing of the 
second recombinant is  currently under way.) Thus,  in  the linkage test, recom- 
binants between H-2 and It-1  are in fact intra  /t-2 crossovers. These  results 
permit assignment of It-1 to a position between the H-2K locus and the Ss-Slp 
locus. McDEVITT, DEAK, SHREFFLER,  KLEIN,  STIMPFLING, SNELL  1277 
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